Chinese Proprietary Medicine Xianling Gubao Capsule for Osteoporosis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

OBJECTIVE: To assess the benefit and harm of Chinese medicine Xianling Gubao (XLGB) capsule compared to conventional medication or placebo to inform clinical practice. METHODS: We included randomized controlled trials (RCTs) with Jadad score ≥3 of XLGB capsule compared to pharmaceutical medication,...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Bai-Ru, Wu, Rou-Yan, Gao, Qin-Yang, Jiang, Kai-Xin, Li, Shuang-Sang, Qi, Shi-Hao, Yuan, Ming-Yi, Liu, Jian-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022208/
https://www.ncbi.nlm.nih.gov/pubmed/35464071
http://dx.doi.org/10.3389/fendo.2022.870277

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022208/
https://www.ncbi.nlm.nih.gov/pubmed/35464071
http://dx.doi.org/10.3389/fendo.2022.870277

Ejemplares similares